摘要
几项临床研究表明,皮肤暴露于太阳紫外线 (UV) 辐射会导致不良影响,例如炎症、氧化应激和 DNA 损伤。因此,可能会出现不同的皮肤病,其中包括皮肤癌,包括非黑色素瘤皮肤癌 (NMSC) 和黑色素瘤 (MM)。酚类化合物是植物来源的次级代谢产物,具有众所周知的抗氧化活性,能够抵消紫外线辐射的负面影响。在这篇综述中,我们讨论了一些选定的酚对 NMSC 和 MM 的影响,证明它们可用于预防和治疗这些类型的肿瘤。此外,我们报告了这些酚类发挥抗肿瘤作用的机制。体外和体内研究强调,许多酚类能够诱导光保护、细胞凋亡和自噬。它们还可以减少 DNA 甲基化、肿瘤发生、肿瘤发生率和增殖。此外,我们描述了一些植物提取物的例子,它们的抗癌活性似乎比单一酚类更好。尽管实验方法存在差异,但结果出现了很大的一致性。因此,这里汇编的知识可以为进行一些组织良好的临床试验提供基础,以验证一些酚类化合物对 NMSC 和 MM 患者的化学预防和治疗潜力。
关键词: 皮肤癌、酚类化合物、氧化应激、植物提取物、黑色素瘤、化学预防、非黑色素瘤皮肤癌。
Current Medicinal Chemistry
Title:Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review
Volume: 28 Issue: 33
关键词: 皮肤癌、酚类化合物、氧化应激、植物提取物、黑色素瘤、化学预防、非黑色素瘤皮肤癌。
摘要: Several clinical studies have shown that exposure of skin to solar ultraviolet (UV) radiation causes adverse effects, such as inflammation, oxidative stress and DNA damage. As a result, different skin disorders can arise, among which are skin cancer, including non-melanoma skin cancer (NMSC) and melanoma (MM). Phenolic compounds are plant-derived secondary metabolites with a well-known antioxidant activity, able to counteract the negative effects of UV radiation. In this review, we discuss the effects of some selected phenols on NMSC and MM, demonstrating that they can be useful in the prevention and in the treatment of these types of tumors. Moreover, we report the mechanisms by which these phenols carry out their antitumor action. In vitro and in vivo studies have highlighted that many phenols are capable of inducing photoprotection, apoptosis and autophagy. They can also reduce DNA methylation, tumorigenesis, tumor incidence and proliferation. Moreover, we describe some examples of plant extracts, whose anticancer activity appears to be better than that of single phenols. A great concordance of results emerged, despite the differences in experimental methods. Therefore, the knowledge compiled here could provide the basis for conducting some well-organized clinical trials to validate the chemopreventive and the therapeutic potential of some phenolic compounds in patients with NMSC and MM.
Export Options
About this article
Cite this article as:
Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review, Current Medicinal Chemistry 2021; 28 (33) . https://dx.doi.org/10.2174/0929867328666210324160324
DOI https://dx.doi.org/10.2174/0929867328666210324160324 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine
Recent Patents on Cardiovascular Drug Discovery Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Vascular Endothelial Dysfunction
Current Drug Targets Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews In Vitro Inhibition Of Three Different Drugs Used In Rheumatoid Arthritis Treatment On Human Serum Paraoxanase 1 Enzyme Activity
Protein & Peptide Letters Therapeutic Potential of Non-Coding RNAs and TLR Signalling Pathways in Rheumatoid Arthritis
Current Pharmaceutical Biotechnology Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
Current Pharmaceutical Design Oncogenic Fusion Tyrosine Kinases as Molecular Targets for Anti-Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Drug-Induced Aseptic Meningitis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Current Medicinal Chemistry Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)]
Current Pharmaceutical Design The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies
Current Respiratory Medicine Reviews Childhood Systemic Lupus Erythematosus: New and Old Treatments
Current Pediatric Reviews Selenium and Autoimmune Diseases: A Review Article
Current Rheumatology Reviews Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Current Pharmaceutical Design Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Identification of Apoptotic Drugs: Multiparametric Evaluation in Cultured Hepatocytes
Current Medicinal Chemistry Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Role of Oxidized Phospholipids in Acute Lung Injury
Current Respiratory Medicine Reviews Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued)